Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Lung Cancer-Specific Mortality Risk and Public Health Insurance

A Prospective Cohort Study in Chongqing, Southwest China

Bibliographic Data

ID22091020
AuthorsYuqi Wang (0009-0000-8683-4185, Chongqing University), Haike Lei (0000-0003-0284-2052, Chongqing University), Xiaosheng Li (0000-0001-8526-7094, Chongqing University), Wei Zhou (0000-0002-0849-1524, Chongqing University), Guixue Wang (0000-0002-9192-8757, Chongqing University), Anlong Sun (Chongqing University), Ying Wang (0000-0003-3126-1134, Chongqing University), Yongzhong Wu (0000-0001-8367-3347, Chongqing University, corresponding author), Bin Peng (0000-0001-5672-2086, Chongqing Public Health Medical Center, corresponding author)
Year2022
Volume10
Pages842844-842844
Publication date2022-04-29
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueFrontiers in Public Health (JOURNAL)
Journal identifiersISSN: 2296-2565 • E-ISSN: 2296-2565
PublisherFrontiers Media SA (PUBLISHER • CH)
DOI10.3389/fpubh.2022.842844
PMID35570974
OpenAlexW4225153254
LanguageEN
Citations received4
References cited25

Objective The incidence and mortality of lung cancer rank first among malignant tumors, and its long treatment cycle will bring serious economic burdens to lung cancer patients and their families. There are few studies on the prognosis of lung cancer and insurance policies. This article explores the relationship between the lung cancer-specific death and public health insurance, self-paying rate, and the joint effect of public health insurance and self-paying rate. Materials and Methods A prospective longitudinal cohort study was conducted in Chongqing, China from 2013 to 2019. The selected subjects were patients with C33–C34 coded according to the tenth edition of the International Classification of Diseases (ICD-10), aged 20 years or older. We conduct a subgroup analysis based on public health insurance types and self-paying rates. After following the inclusion and exclusion criteria, the chi-square test was used to describe the demographic and clinical characteristics of patients with different insurance types and different self-paying rates. Multivariate logistic regression was used to analyze the relationship between patients with different insurance types, self-paying rates, and lung cancer treatment methods. Finally, the Cox proportional hazard model and the competitive risk model are used to calculate the cumulative hazard ratio of all-cause death and lung cancer-specific death for different insurance types and different self-paying rate groups. Results A total of 12,464 patients with lung cancer were included in this study. During the follow-up period (median 13 months, interquartile range 5.6–25.2 months), 5,803 deaths were observed, of which 3,781 died of lung cancer. Compared with patients who received urban resident-based basic medical insurance (URBMI), patients who received urban employee-based basic medical insurance (UEBMI) had a 38.1% higher risk of lung cancer-specific death (Hazard Ratios (HRs) = 1.381, 95% confidence interval (CI): 1.293–1.476, P < 0.005), Compared with patients with insufficient self-paying rate, patients with a higher self-paying rate had a 40.2% lower risk of lung cancer-specific death (HRs = 0.598, 95% CI: 0.557–0.643, P < 0.005). Every 10% increase in self-paying rate of URBMI reduces the risk of lung cancer-specific death by 17.6%, while every 10% increase in self-paying rate of UEBMI reduces the risk of lung cancer-specific death by 18.0%. Conclusions The National Medical Security Administration should, under the condition of limited medical insurance funds, try to include the original self-paid anti-tumor drugs into the national medical insurance coverage. This can not only reduce the mortality rate of lung cancer patients, but also reduce the family burden of lung cancer patients. On the other hand, high-risk groups should increase their awareness of lung cancer screening and actively participate in the national cancer screening project led by the state

Cancer · Cohort · Confidence interval · Hazard ratio · Interquartile range · Lung cancer · Pathology · Proportional hazards model · Prospective cohort study · Public health · Demography · Economic and Financial Impacts of Cancer · Global Cancer Incidence and Screening · Healthcare Systems and Reforms · Medicine · Internal Medicine

  • Effects of Tobacco Smoking on the Survivability of Patients with Multiple Cancers and Single Lung Cancer

    Open Access•Anna Romaszko–Wojtowicz, Andżelika Lorenc et al.•International Journal of…•2022

  • Association of public health insurance with cancer-specific mortality risk among patients with nasopharyngeal carcinoma

    Open Access•Dan Li, Hai-Ke Lei et al.•Frontiers in Public Health•2023

  • A structural equation model analysis of the relationship between social support and depression in lung cancer patients

    Open Access•Cuiting Jiang, Tingting Liu et al.•Current Psychology•2024

  • Disparities in inpatient treatment and expenditures among lung cancer patients under tiered social health insurance

    Open Access•Yaoyun Zhang, Yu He et al.•International Journal for Equity…•2025

  • Global cancer statistics 2018

    Open Access•Francesca Bray, Freddie Bray et al.•CA: A Cancer Journal for Clinicians•2018

  • The impacts of government reimbursement negotiation on targeted anticancer medication price, volume and spending in China

    Open Access•Yichen Zhang, Haishaerjiang Wushouer et al.•BMJ Global Health•2021

  • Economic Burden for Lung Cancer Survivors in Urban China

    Open Access•Xin Zhang, Shuai Liu et al.•International Journal of…•2017

  • Availability, Price and Affordability of Anticancer Medicines

    Open Access•Yulei Zhu, Ying Wang et al.•International Journal of…•2019

  • Economic burden of lung cancer attributable to smoking in China in 2015

    Jufang Shi, Chengcheng Liu et al.•Tobacco Control•2019

Unique citing works4
Citations per year1
Citation span2022 - 2025 (4)
Citation velocityrecent
Highly citedNo
Citation typesNeutral: 4

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae